High-Risk Prostate Cancer · Фаза 2 · NCT05593497
Capivasertib, abiraterone acetate
VA Office of Research and Development · Open the brief
Cancer Of Prostate · Фаза 2 · NCT05361798
PDS01ADC, Stereotactic Body Radiation Therapy (SBRT)
National Cancer Institute (NCI) · Open the brief
Prostate Cancer · Фаза 2 · NCT07237269
Androgen Deprivation Therapy (ADT), Abiraterone, Prednisone, Radiation Therapy
University of Nebraska · Open the brief
Prostate Cancer · Фаза 2 · NCT06096870
Enzalutamide, PDS01ADC
National Cancer Institute (NCI) · Open the brief
Castration-Sensitive Prostate Adenocarcinoma · Фаза 2 · NCT07466498
Androgen Receptor Pathway Inhibitor, Transdermal Estrogen, Bone Scan, Computed Tomography
Fred Hutchinson Cancer Center · Open the brief
Prostatic Neoplasms · Фаза 2 · NCT05616650
18F-DCFPyL, Stereotactic Body Radiation Therapy
National Cancer Institute (NCI) · Open the brief
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation · Фаза 2 · NCT05691465
Biospecimen Collection, Computed Tomography, Gallium Ga 68-DOTATATE, Lutetium Lu 177 Dotatate
National Cancer Institute (NCI) · Open the brief
Castration-Sensitive Prostate Carcinoma · Фаза 2 · NCT06244004
Antiandrogen Therapy, Bone Scan, Computed Tomography, Cytotoxic Chemotherapy
Northwestern University · Open the brief
Castration-Resistant Prostate Cancer (CRPC) · Фаза 2 · NCT07745361
Oral MRT-2359, Apalutamide
Monte Rosa Therapeutics, Inc · Open the brief
Castration-resistant Prostate Cancer · Фаза 2 · NCT05534646
AR Blockade, Carotuximab
Edwin Posadas, MD · Open the brief
Metastatic Prostate Cancer · Фаза 2 · NCT06738303
Cabazitaxel and carboplatin, Lu-PSMA-617
Case Comprehensive Cancer Center · Open the brief
PSMA PET-Positive Castration-Resistant Prostate Cancer · Фаза 2 · NCT06549465
In-111 rosopatamab tetraxetan, 45 kBq/kg Ac-225 rosopatamab tetraxetan, 45 kBq/kg or equivalent fixed dose activity Ac-225 rosopatamab tetraxetan, 60 kBq/kg Ac-225 rosopatamab tetraxetan
Convergent Therapeutics · Open the brief
Prostatic Neoplasms · Фаза 2 · NCT07832292
JNJ-101556143
Janssen Research & Development, LLC · Open the brief
Prostate Cancer · Фаза 2 · NCT07234981
PSMA-guided Salvage Radiation
University of Nebraska · Open the brief
Metastatic Prostate Cancer · Фаза 2 · NCT05011383
High dose testosterone
VA Office of Research and Development · Open the brief
Prostate Cancer · Фаза 2 · NCT06150417 · Papers
Androgen deprivation therapy (ADT), Androgen receptor signaling inhibitor (ARSI), Local Therapy: Radical Prostatectomy (RP) or Radiotherapy (RT), Metastasis directed radiotherapy (MDRT)
Case Comprehensive Cancer Center · Open the brief
Prostate Cancer · Фаза 2 · NCT06111781
Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment
Yale University · Open the brief
Castrate Resistant Prostate Cancer · Фаза 2 · NCT05766371
Pembrolizumab, 177Lu-PSMA-617
University of California, San Francisco · Open the brief
Prostate Cancer · Фаза 2 · NCT07226713
Pacritinib
Medical College of Wisconsin · Open the brief
Prostate Cancer · Фаза 2 · NCT07005154
ASP5541, Prednisone, Prednisolone, abiraterone acetate
Astellas Pharma Global Development, Inc. · Open the brief
Prostate Cancer · Фаза 2 · NCT07801664
Androgen Deprivation Therapy (ADT), Radiotherapy
NYU Langone Health · Open the brief
Prostate Cancer · Фаза 2 · NCT05726292
Relacorilant, Enzalutamide, Placebo (Sugar Pill), Androgen Deprivation Therapy
University of Chicago · Open the brief
Metastatic Prostate Cancer · Фаза 2 · NCT07111507
Tarlatamab
Memorial Sloan Kettering Cancer Center · Open the brief
Aggressive Variant Prostate Carcinoma · Фаза 2 · NCT07218666
Zanzalintinib
Deepak Kilari · Open the brief